nodes	percent_of_prediction	percent_of_DWPC	metapath
Carprofen—PTGS1—malignant glioma	0.622	0.636	CbGaD
Carprofen—PTGS2—malignant glioma	0.356	0.364	CbGaD
Carprofen—Ibuprofen—BCL2—malignant glioma	0.001	0.116	CrCbGaD
Carprofen—Suprofen—PTGS1—malignant glioma	0.000821	0.0951	CrCbGaD
Carprofen—Ketoprofen—CXCL8—malignant glioma	0.000818	0.0949	CrCbGaD
Carprofen—Ibuprofen—CXCL8—malignant glioma	0.000806	0.0934	CrCbGaD
Carprofen—Fenoprofen—PTGS1—malignant glioma	0.000707	0.082	CrCbGaD
Carprofen—Naproxen—PTGS1—malignant glioma	0.000644	0.0747	CrCbGaD
Carprofen—Ibuprofen—PPARG—malignant glioma	0.000557	0.0645	CrCbGaD
Carprofen—PTGS2—S1P1 pathway—SPHK1—malignant glioma	0.00048	0.0353	CbGpPWpGaD
Carprofen—Suprofen—PTGS2—malignant glioma	0.000469	0.0544	CrCbGaD
Carprofen—Flurbiprofen—PTGS1—malignant glioma	0.000462	0.0535	CrCbGaD
Carprofen—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—malignant glioma	0.000455	0.0334	CbGpPWpGaD
Carprofen—Ketoprofen—PTGS1—malignant glioma	0.000418	0.0484	CrCbGaD
Carprofen—Ibuprofen—PTGS1—malignant glioma	0.000411	0.0477	CrCbGaD
Carprofen—Fenoprofen—PTGS2—malignant glioma	0.000404	0.0469	CrCbGaD
Carprofen—PTGS2—C-MYB transcription factor network—YEATS4—malignant glioma	0.000404	0.0297	CbGpPWpGaD
Carprofen—Naproxen—PTGS2—malignant glioma	0.000368	0.0427	CrCbGaD
Carprofen—PTGS2—Overview of nanoparticle effects—PTGS1—malignant glioma	0.000357	0.0262	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—PTK2—malignant glioma	0.000313	0.023	CbGpPWpGaD
Carprofen—PTGS2—Eicosanoid Synthesis—PTGS1—malignant glioma	0.000296	0.0217	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—ROS1—malignant glioma	0.000274	0.0201	CbGpPWpGaD
Carprofen—Flurbiprofen—PTGS2—malignant glioma	0.000264	0.0306	CrCbGaD
Carprofen—PTGS2—Overview of nanoparticle effects—PTK2—malignant glioma	0.000248	0.0182	CbGpPWpGaD
Carprofen—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—malignant glioma	0.000247	0.0182	CbGpPWpGaD
Carprofen—Ketoprofen—PTGS2—malignant glioma	0.000239	0.0277	CrCbGaD
Carprofen—PTGS1—Overview of nanoparticle effects—FN1—malignant glioma	0.000237	0.0174	CbGpPWpGaD
Carprofen—Ibuprofen—PTGS2—malignant glioma	0.000235	0.0272	CrCbGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000232	0.017	CbGpPWpGaD
Carprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000221	0.0162	CbGpPWpGaD
Carprofen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—malignant glioma	0.00022	0.0161	CbGpPWpGaD
Carprofen—PTGS2—S1P1 pathway—PDGFB—malignant glioma	0.000209	0.0153	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—PIM1—malignant glioma	0.000207	0.0152	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000199	0.0146	CbGpPWpGaD
Carprofen—PTGS2—S1P1 pathway—KDR—malignant glioma	0.000195	0.0144	CbGpPWpGaD
Carprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000192	0.0141	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—FN1—malignant glioma	0.000188	0.0138	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—BCL2—malignant glioma	0.000181	0.0133	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—PTGS2—malignant glioma	0.000172	0.0126	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000167	0.0123	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—BCAN—malignant glioma	0.000166	0.0122	CbGpPWpGaD
Carprofen—PTGS2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000164	0.0121	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000158	0.0116	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—BCL2—malignant glioma	0.000144	0.0106	CbGpPWpGaD
Carprofen—PTGS1—Eicosanoid Synthesis—PTGS2—malignant glioma	0.000143	0.0105	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—MYB—malignant glioma	0.000138	0.0101	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—GDNF—malignant glioma	0.000134	0.00984	CbGpPWpGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000134	0.00982	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000133	0.00974	CbGpPWpGaD
Carprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.000132	0.00967	CbGpPWpGaD
Carprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—malignant glioma	0.000124	0.00907	CbGpPWpGaD
Carprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.000119	0.00878	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—CYP2B6—malignant glioma	0.000117	0.00862	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—TNF—malignant glioma	0.000116	0.00854	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—GFAP—malignant glioma	0.000115	0.00846	CbGpPWpGaD
Carprofen—PTGS2—S1P1 pathway—VEGFA—malignant glioma	0.000108	0.00791	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000105	0.00769	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—CYP2C18—malignant glioma	0.000102	0.00747	CbGpPWpGaD
Carprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malignant glioma	0.000102	0.00747	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—LGALS3—malignant glioma	0.000101	0.00739	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—SOD1—malignant glioma	9.99e-05	0.00734	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	9.61e-05	0.00706	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—CAT—malignant glioma	9.49e-05	0.00697	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—TNF—malignant glioma	9.23e-05	0.00678	CbGpPWpGaD
Carprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malignant glioma	9.03e-05	0.00663	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—COX8A—malignant glioma	8.74e-05	0.00642	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—GSTT1—malignant glioma	8.23e-05	0.00604	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—malignant glioma	8.01e-05	0.00588	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—FTH1—malignant glioma	7.99e-05	0.00587	CbGpPWpGaD
Carprofen—PTGS1—Arachidonic acid metabolism—PTGS2—malignant glioma	7.94e-05	0.00583	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—SOD1—malignant glioma	7.93e-05	0.00582	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—CAT—malignant glioma	7.53e-05	0.00553	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—HES1—malignant glioma	7.42e-05	0.00545	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—NCOR1—malignant glioma	7.38e-05	0.00542	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	7.28e-05	0.00535	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	6.98e-05	0.00513	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	6.96e-05	0.00512	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—F2—malignant glioma	6.95e-05	0.00511	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	6.9e-05	0.00507	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—APOD—malignant glioma	6.79e-05	0.00499	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malignant glioma	6.57e-05	0.00483	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—GJA1—malignant glioma	6.49e-05	0.00477	CbGpPWpGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	6.29e-05	0.00462	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	6.15e-05	0.00452	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—malignant glioma	6.11e-05	0.00449	CbGpPWpGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	5.98e-05	0.0044	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—malignant glioma	5.85e-05	0.0043	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malignant glioma	5.84e-05	0.00429	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—RTEL1—malignant glioma	5.77e-05	0.00424	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—GSTP1—malignant glioma	5.7e-05	0.00419	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	5.63e-05	0.00413	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	5.52e-05	0.00405	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	5.31e-05	0.0039	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—IFNG—malignant glioma	5.27e-05	0.00387	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—PTGS2—malignant glioma	5.05e-05	0.00371	CbGpPWpGaD
Carprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	4.99e-05	0.00367	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	4.88e-05	0.00359	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	4.78e-05	0.00351	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—IL1B—malignant glioma	4.7e-05	0.00345	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—RTEL1—malignant glioma	4.58e-05	0.00336	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	4.55e-05	0.00334	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	4.51e-05	0.00331	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	4.45e-05	0.00327	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	4.38e-05	0.00322	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	4.38e-05	0.00322	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	4.25e-05	0.00313	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	4.18e-05	0.00307	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.12e-05	0.00303	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	4.07e-05	0.00299	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	4.03e-05	0.00296	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.99e-05	0.00293	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	3.73e-05	0.00274	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	3.66e-05	0.00269	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	3.48e-05	0.00256	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	3.41e-05	0.0025	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—COX8A—malignant glioma	3.31e-05	0.00243	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	3.31e-05	0.00243	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	3.27e-05	0.00241	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.27e-05	0.0024	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.19e-05	0.00235	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.17e-05	0.00233	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	3.07e-05	0.00226	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.04e-05	0.00223	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	3.02e-05	0.00222	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	2.95e-05	0.00217	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	2.94e-05	0.00216	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—IL2—malignant glioma	2.94e-05	0.00216	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	2.93e-05	0.00215	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	2.84e-05	0.00209	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—ASMT—malignant glioma	2.82e-05	0.00207	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	2.81e-05	0.00206	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	2.79e-05	0.00205	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	2.78e-05	0.00204	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.75e-05	0.00202	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	2.71e-05	0.00199	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—BCAN—malignant glioma	2.65e-05	0.00194	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—COX8A—malignant glioma	2.63e-05	0.00193	CbGpPWpGaD
Carprofen—PTGS2—Disease—BCAN—malignant glioma	2.51e-05	0.00184	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	2.39e-05	0.00176	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.35e-05	0.00173	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—MYC—malignant glioma	2.3e-05	0.00169	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	2.27e-05	0.00167	CbGpPWpGaD
Carprofen—PTGS2—Disease—DTX1—malignant glioma	2.27e-05	0.00167	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	2.25e-05	0.00165	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	2.24e-05	0.00164	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—ASMT—malignant glioma	2.24e-05	0.00164	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	2.23e-05	0.00164	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	2.21e-05	0.00162	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.18e-05	0.00161	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—TNF—malignant glioma	2.14e-05	0.00157	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—IDH2—malignant glioma	2.13e-05	0.00157	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—BCAN—malignant glioma	2.1e-05	0.00154	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.01e-05	0.00148	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CYP2B6—malignant glioma	2.01e-05	0.00147	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2e-05	0.00147	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—TP53—malignant glioma	1.89e-05	0.00139	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.88e-05	0.00138	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—IDH1—malignant glioma	1.84e-05	0.00135	CbGpPWpGaD
Carprofen—PTGS2—Disease—HEY2—malignant glioma	1.78e-05	0.00131	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—SPHK1—malignant glioma	1.78e-05	0.0013	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CYP2C18—malignant glioma	1.74e-05	0.00128	CbGpPWpGaD
Carprofen—PTGS2—Disease—IDH1—malignant glioma	1.74e-05	0.00128	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.7e-05	0.00125	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—IDH2—malignant glioma	1.69e-05	0.00124	CbGpPWpGaD
Carprofen—PTGS2—Disease—HEY1—malignant glioma	1.65e-05	0.00121	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.64e-05	0.00121	CbGpPWpGaD
Carprofen—PTGS2—Disease—HIST1H3B—malignant glioma	1.6e-05	0.00118	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.6e-05	0.00117	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CYP2B6—malignant glioma	1.59e-05	0.00117	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.56e-05	0.00115	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.53e-05	0.00112	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.49e-05	0.0011	CbGpPWpGaD
Carprofen—PTGS2—Disease—JAG2—malignant glioma	1.46e-05	0.00107	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—IDH1—malignant glioma	1.46e-05	0.00107	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.46e-05	0.00107	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.44e-05	0.00106	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.44e-05	0.00106	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—SPHK1—malignant glioma	1.41e-05	0.00104	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GSTT1—malignant glioma	1.41e-05	0.00103	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CYP2C18—malignant glioma	1.38e-05	0.00101	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	1.38e-05	0.00101	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.33e-05	0.000975	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.31e-05	0.000965	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.3e-05	0.000957	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.28e-05	0.000943	CbGpPWpGaD
Carprofen—PTGS2—Disease—H3F3A—malignant glioma	1.24e-05	0.000909	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—BCHE—malignant glioma	1.23e-05	0.0009	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—SLC5A5—malignant glioma	1.21e-05	0.000889	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.19e-05	0.000871	CbGpPWpGaD
Carprofen—PTGS2—Disease—JAG1—malignant glioma	1.17e-05	0.000857	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.14e-05	0.000841	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.14e-05	0.000841	CbGpPWpGaD
Carprofen—PTGS2—Disease—FBXW7—malignant glioma	1.14e-05	0.00084	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.13e-05	0.000833	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GSTT1—malignant glioma	1.12e-05	0.000821	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.08e-05	0.000796	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PTGS1—malignant glioma	1.05e-05	0.000769	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.04e-05	0.000766	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.89e-06	0.000727	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GSTP1—malignant glioma	9.75e-06	0.000716	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—BCHE—malignant glioma	9.73e-06	0.000715	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—SLC5A5—malignant glioma	9.61e-06	0.000706	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CAT—malignant glioma	9.49e-06	0.000697	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.09e-06	0.000668	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—NCOR1—malignant glioma	8.96e-06	0.000658	CbGpPWpGaD
Carprofen—PTGS2—Disease—CDKN2B—malignant glioma	8.96e-06	0.000658	CbGpPWpGaD
Carprofen—PTGS2—Disease—HES1—malignant glioma	8.54e-06	0.000628	CbGpPWpGaD
Carprofen—PTGS2—Disease—NCOR1—malignant glioma	8.5e-06	0.000624	CbGpPWpGaD
Carprofen—PTGS2—Disease—PDGFRA—malignant glioma	8.14e-06	0.000598	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.85e-06	0.000577	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GSTP1—malignant glioma	7.74e-06	0.000569	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CAT—malignant glioma	7.53e-06	0.000553	CbGpPWpGaD
Carprofen—PTGS2—Disease—TERT—malignant glioma	7.49e-06	0.00055	CbGpPWpGaD
Carprofen—PTGS2—Disease—HLA-A—malignant glioma	7.49e-06	0.00055	CbGpPWpGaD
Carprofen—PTGS2—Disease—PDGFB—malignant glioma	7.31e-06	0.000537	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CAV1—malignant glioma	7.31e-06	0.000537	CbGpPWpGaD
Carprofen—PTGS2—Disease—FGFR1—malignant glioma	7.27e-06	0.000534	CbGpPWpGaD
Carprofen—PTGS2—Disease—HIF1A—malignant glioma	7.16e-06	0.000526	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—NCOR1—malignant glioma	7.11e-06	0.000523	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.98e-06	0.000513	CbGpPWpGaD
Carprofen—PTGS2—Disease—CAV1—malignant glioma	6.93e-06	0.000509	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PIK3CG—malignant glioma	6.65e-06	0.000489	CbGpPWpGaD
Carprofen—PTGS2—Disease—BAD—malignant glioma	6.51e-06	0.000478	CbGpPWpGaD
Carprofen—PTGS2—Disease—NOTCH1—malignant glioma	6.45e-06	0.000474	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PPARG—malignant glioma	6.42e-06	0.000472	CbGpPWpGaD
Carprofen—PTGS2—Disease—CD80—malignant glioma	6.32e-06	0.000464	CbGpPWpGaD
Carprofen—PTGS2—Disease—APC—malignant glioma	6.31e-06	0.000463	CbGpPWpGaD
Carprofen—PTGS2—Disease—EGF—malignant glioma	6.24e-06	0.000458	CbGpPWpGaD
Carprofen—PTGS2—Disease—PTPN11—malignant glioma	6.2e-06	0.000455	CbGpPWpGaD
Carprofen—PTGS2—Disease—BRAF—malignant glioma	5.93e-06	0.000436	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PIK3CD—malignant glioma	5.85e-06	0.00043	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CAV1—malignant glioma	5.8e-06	0.000426	CbGpPWpGaD
Carprofen—PTGS2—Disease—AKT2—malignant glioma	5.77e-06	0.000424	CbGpPWpGaD
Carprofen—PTGS2—Disease—PIK3CD—malignant glioma	5.55e-06	0.000407	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.54e-06	0.000407	CbGpPWpGaD
Carprofen—PTGS2—Disease—FGF2—malignant glioma	5.31e-06	0.00039	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PIK3CG—malignant glioma	5.28e-06	0.000388	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PIK3CB—malignant glioma	5.1e-06	0.000375	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PPARG—malignant glioma	5.1e-06	0.000375	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PTGS2—malignant glioma	5.05e-06	0.000371	CbGpPWpGaD
Carprofen—PTGS2—Disease—MDM2—malignant glioma	4.97e-06	0.000365	CbGpPWpGaD
Carprofen—PTGS2—Disease—RAF1—malignant glioma	4.95e-06	0.000364	CbGpPWpGaD
Carprofen—PTGS2—Disease—ERBB2—malignant glioma	4.9e-06	0.00036	CbGpPWpGaD
Carprofen—PTGS2—Disease—PIK3CB—malignant glioma	4.83e-06	0.000355	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PIK3CD—malignant glioma	4.64e-06	0.000341	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PTEN—malignant glioma	4.41e-06	0.000324	CbGpPWpGaD
Carprofen—PTGS2—Disease—PTEN—malignant glioma	4.18e-06	0.000307	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PIK3CB—malignant glioma	4.05e-06	0.000297	CbGpPWpGaD
Carprofen—PTGS2—Disease—STAT3—malignant glioma	3.74e-06	0.000274	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PTEN—malignant glioma	3.5e-06	0.000257	CbGpPWpGaD
Carprofen—PTGS2—Disease—MYC—malignant glioma	3.47e-06	0.000255	CbGpPWpGaD
Carprofen—PTGS2—Disease—EGFR—malignant glioma	3.4e-06	0.000249	CbGpPWpGaD
Carprofen—PTGS2—Disease—KRAS—malignant glioma	3.21e-06	0.000236	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PIK3CA—malignant glioma	3.11e-06	0.000228	CbGpPWpGaD
Carprofen—PTGS2—Disease—PIK3CA—malignant glioma	2.95e-06	0.000216	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—AKT1—malignant glioma	2.54e-06	0.000187	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PIK3CA—malignant glioma	2.47e-06	0.000181	CbGpPWpGaD
Carprofen—PTGS2—Disease—AKT1—malignant glioma	2.41e-06	0.000177	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—AKT1—malignant glioma	2.02e-06	0.000148	CbGpPWpGaD
